Bioregenx (BRGX) Return on Capital Employed (2023 - 2026)
Bioregenx's quarterly Return on Capital Employed came in at 30.47% in Q1 2026, down 57391.0% year-on-year from N/an in Q1 2025, and down 19.73% quarter-over-quarter from 37.96% in Q4 2025.
Bioregenx has reported Return on Capital Employed for 4 years, with the latest figure at 30.47% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 57391.0% year-over-year to 30.47%; the trailing twelve-month figure through Mar 2026 stood at 30.47% (down 57391.0% YoY), and the FY2025 full-year result was 34.49%, down 73818.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 30.47%, down from 37.96% in the prior quarter.
- The five-year high for Return on Capital Employed was 1771.56% in Q3 2023, with the low at 1841.56% in Q2 2023.
- Average Return on Capital Employed over 4 years is 50.6%, with a median of 30.47% recorded in 2026.
- Peak annual rise in Return on Capital Employed reached 179573 bps in 2024, while the deepest fall reached 180458 bps in 2024.
- Tracing BRGX's Return on Capital Employed over 4 years: stood at 145.84% in 2023, then plunged by 394 bps to 429.35% in 2024, then surged by 109 bps to 37.96% in 2025, then dropped by 20 bps to 30.47% in 2026.
- The last three Return on Capital Employed figures came in at 30.47% (Q1 2026), 37.96% (Q4 2025), and 671.26% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 13.28% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -163.65% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 21.81% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 4.73% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -4.23% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.23% |
| 10 | Bioregenx | - | - | 348,288.00 | 30.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.47% |
| Dec 31, 2025 | 37.96% |
| Sep 30, 2025 | 671.26% |
| Jun 30, 2025 | 609.34% |
| Mar 31, 2025 | 604.38% |
| Dec 31, 2024 | -429.35% |
| Sep 30, 2024 | -33.02% |
| Jun 30, 2024 | -45.83% |
| Mar 31, 2024 | -99.15% |
| Dec 31, 2023 | 145.84% |
| Sep 30, 2023 | 1,771.56% |
| Jun 30, 2023 | -1,841.56% |
| Mar 31, 2023 | -764.15% |